Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/2008
04/30/2008DE202007011825U1 Pharmazeutische Dosierungsformen Pharmaceutical dosage forms
04/30/2008CN101171256A Fused thiazole derivatives having affinity for the histamine h3 receptor
04/30/2008CN101171253A Hydrocodone polymorphs
04/30/2008CN101171238A (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-HT receptor
04/30/2008CN101171235A Dipyrazoles as central nervous system agents
04/30/2008CN101171229A Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid
04/30/2008CN101171228A Pregabalin free of isobutylglutaric acid and a process for preparation thereof
04/30/2008CN101171227A Pregabalin free of lactam and a process for preparation thereof
04/30/2008CN101171029A Agent for treating and/or preventing of neuropathic pain
04/30/2008CN101171009A Treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine h3- receptor ligands
04/30/2008CN101171004A Therapeutic use of nefopam and analogues thereof
04/30/2008CN101171003A Cytokine modulators using cyclic glycerides of essential poyunsaturated fatty acids
04/30/2008CN101168058A Mixture preparation
04/30/2008CN101168057A Dopamine agonist preparation
04/30/2008CN101168056A 混合物制剂 Mixture preparation
04/30/2008CN101168048A Application of cerebral tissue fluid and nerve growth factor in preparing combination medicine for treating infantile cerebral paralysis
04/30/2008CN101168036A Orally-administered traditional Chinese medicinal composition for treating migraine pain
04/30/2008CN101168026A Traditional Chinese medicine for treating alcohol dependence disease
04/30/2008CN101168025A Medicine composition for preventing and treating senile dementia
04/30/2008CN101168024A Proprietary Chinese medicine for treating depression and production method thereof
04/30/2008CN101168010A Infantile heat excess wind-getting resuscitation tranquilization medicine
04/30/2008CN101168009A Quality control method of macaque stone bovinebezoar powder
04/30/2008CN101168007A Medicine for treating cerebral palsy diseases and its preparing process
04/30/2008CN101167999A Hot compress exergy and preparation method thereof
04/30/2008CN101167968A Traditional Chinese medicine for treating infantile paralytic sequelae
04/30/2008CN101167965A Traditional Chinese medicinal composition for treating senile parkinsonian syndrome
04/30/2008CN101167952A Donkey-hide gelatin and pine needle wine
04/30/2008CN101167943A Wine capable of prolonging life
04/30/2008CN101167912A Medicine for treating spastic cerebral paralysis disease and its preparing method
04/30/2008CN101167905A Health product for sobering-up, alcoholism-eliminating and fatty liver prevention
04/30/2008CN101167901A Chinese angelica and peony formula extraction, preparation and medical use thereof
04/30/2008CN101167898A Traditional Chinese medicine preparation for treating insomnia
04/30/2008CN101167873A Technology for processing honey-prepared glutinous rehmannia
04/30/2008CN101167849A Traditional Chinese medicine for treating enuresis caused by fright suddenly
04/30/2008CN101167836A Medicinal liquor for treating sciatica
04/30/2008CN101167817A Traditional Chinese medicine for treating migraine
04/30/2008CN101167814A Traditional Chinese medicine for treating kidney yin deficiency and deficiency of both yin and yang and preparation method
04/30/2008CN101167803A Fresh schisandra chinensis extract and its preparation and application
04/30/2008CN101167786A Process of extracting total flavone from fordia cauliflora Hemsl
04/30/2008CN101167697A Donepezils compound long-acting slow-releasing and controlled-releasing composition and preparation method thereof
04/30/2008CN100385005C Methods for the production of multimeric proteins, and related compositions
04/30/2008CN100384986C Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease
04/30/2008CN100384877C Antibody ('11c7') anti nogo a and its pharmaceutical use
04/30/2008CN100384863C Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
04/30/2008CN100384850C Galantamine derivative and its preparation process and use
04/30/2008CN100384849C Quinoline 3-amino chroman derivatives
04/30/2008CN100384847C Adenosine a2a receptor antagonists
04/30/2008CN100384843C CGRP receptor antagonists
04/30/2008CN100384841C Polymorphic forms of 1-4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
04/30/2008CN100384836C Novel cyclic amide derivatives
04/30/2008CN100384833C Therapeutic chroman compounds
04/30/2008CN100384825C Benzheterocyclic derivatives
04/30/2008CN100384824C Acetyl 2-hydroxy-1, 3-diaminoalkanes
04/30/2008CN100384822C 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
04/30/2008CN100384820C Phosphate prodrugs of fluorooxindoles
04/30/2008CN100384477C Complex of modafinil and cyclodextrin
04/30/2008CN100384430C Combination therepy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators
04/30/2008CN100384418C Isoxazolopyridinones and use thereof in the treatment of parkinson's disease
04/30/2008CN100384411C Oral carbidopa/levodopa disintegrant tablet
04/30/2008CN100384410C Parenteral dosage forms comprising suspension of tramadol salt and diclofenac salt
04/29/2008USRE40278 Heterocyclic amines having central nervous system activity
04/29/2008US7365216 Process for the production of citalopram
04/29/2008US7365211 Heterocyclic GABAA subtype selective receptor modulators
04/29/2008US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives
04/29/2008US7365172 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor; stimulate hematopoiesis; diabetes, rheumatoid arthritis, lupus, and multiple sclerosis
04/29/2008US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents
04/29/2008US7365155 Immunoregulator
04/29/2008US7365089 Triazolo-quinolin derivatives useful as adenosine receptor ligands
04/29/2008US7365083 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one
04/29/2008US7365067 Neurokinin receptors antagonists; asthma, bronchitis and chronic obstructive lung disease; allergic diseases such as rhinitis, urinary incontinence; 1-(2-{(2R)-2-(3,4dichlorophenyl)-4-[3,5-bis(trifluoromethyl)benzoyl]morpholin-2-yl}ethyl)spiro((2S)-2-{[(morpholin-1-yl)acetyl]oxy})indane-1,4'-piperidine
04/29/2008US7365064 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them
04/29/2008US7365062 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema or ischemia
04/29/2008US7365049 Afamin-containing compositions and methods of use
04/29/2008US7364867 Nucleotide sequences which code a membrane protein for use in flavor intensification of in food, beverages or pharmaceuticals
04/29/2008US7364847 nucleic acid that binds to high mobility group protein-I (HMG-I), and causes presenilin-2 gene exon 5-lacked type aberrant splicing by the association with the HMG-I protein; an inhibitor for inhibiting a binding between protein-nucleic acid caused by aberrant splicing; drug screening; antisense agents
04/29/2008US7364845 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders
04/29/2008US7364730 Human K+ channel and prognosing applications thereof
04/29/2008CA2394037C New derivatives of benzene sulfonamide, their preparation process and pharmaceutical compositions that contain them
04/29/2008CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
04/29/2008CA2321188C Derivatives of azetidine and pyrrolidine
04/29/2008CA2297732C Heterocyclic vinylethers against neurological disorders
04/29/2008CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders
04/29/2008CA2218887C Piperazino derivatives as neurokinin antagonists
04/24/2008WO2008049073A2 Compositions for the treatment of inflammation in the brain and other tissues
04/24/2008WO2008049058A2 Cln2 treatment of alzheimer's disease
04/24/2008WO2008048670A2 Compositions and methods for modulating tlr14 activity
04/24/2008WO2008048648A2 Cb1-modulating compounds and their use
04/24/2008WO2008048609A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
04/24/2008WO2008048503A2 Imidazole substitured pyrazole kinase inhibitors
04/24/2008WO2008048194A1 Use of the protein kinase c inhibitor tamoxifen for the treatment of bipolar disorder
04/24/2008WO2008048171A1 N- (2 -hydroxyethyl) -n-methyl- 4- (quinolin- 8-yl (1- (thiazol-4- ylmethyl) piperidin- 4 -ylidene) methyl) benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression.
04/24/2008WO2008047952A2 Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound
04/24/2008WO2008047951A2 An alzheimer' s disease progression inhibitor containing heterocyclic compound
04/24/2008WO2008047883A1 Piperazine-substituted benzothiophenes for treatment of mental disorders
04/24/2008WO2008047839A1 5-ht1a receptor agonist
04/24/2008WO2008047821A1 Fused heterocyclic compound
04/24/2008WO2008047709A1 Nk1 receptor antagonist composition
04/24/2008WO2008047544A1 Diaryl ketimine derivative
04/24/2008WO2008047167A1 Polymorphs of o-desmethyl venlafaxine succinate
04/24/2008WO2008046919A2 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors